Serum Autoantibody Lowering by the Anti-FcRn Monoclonal Antibody, Nipocalimab, Correlates With Clinical Improvement in Generalized Myasthenia Gravis Patients

被引：0
|
作者：
Ramchandren, Sindhu
Guptill, Jeff
Antozzi, Carlo
Bril, Vera
Gamez, Josep
Meuth, Sven
Nowak, Richard
Quan, Dianna
Mantecon, Maria Teresa Sevilla
Ling, Leona
Zhu, Yaowei
Karcher, Keith
Sun, Hong
机构：
来源：
NEUROLOGY | 2022年 / 99卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
下载
收藏
页码：S35 / S37
页数：5
相关论文
共 32 条
  • [21] Analysis of clinical features and outcomes in patients with ocular myasthenia gravis according to anti-acetylcholine receptor antibody-seropositivity
    Lee, Byung Joo
    Park, Jimin
    Ahn, Hyosook
    Lim, Hyun Taek
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2024, : 681 - 687
  • [22] Anti-idiotypic T cells in early stages of myasthenia gravis: Increase in the number and prevalence correlated to clinical improvement in patients
    Yi, Q
    Pirskanen, R
    Lefvert, AK
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1996, 44 (06) : 630 - 637
  • [23] CORRELATION BETWEEN SERUM ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY-LEVELS AND CLINICAL STATE UNDER IMMUNOSUPPRESSIVE THERAPY IN MYASTHENIA-GRAVIS
    SCHUMM, F
    FATEHMOGHADAM, A
    DICHGANS, J
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1984, 234 (04) : 224 - 230
  • [24] Serum markers associated with improvement in clinical response measures in RA patients treated with golimumab, a new human anti-TNFα monoclonal antibody
    Visvanathan, S.
    Rahman, M. U.
    Keystone, E. C.
    Genovese, M. C.
    Klareskog, L.
    Hsia, E. C.
    Mack, M.
    Elashoff, M.
    Wagner, C. L.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S777 - S777
  • [25] EFFICACY OF EFGARTIGIMOD TREATMENT IN PATIENTS WITH ANTI-ACETYLCHOLINE RECEPTOR ANTIBODY NEGATIVE MYASTHENIA GRAVIS: CLINICAL TRIAL AND REAL-WORLD DATA
    Papsdorf, Tania
    Durrani, Jon
    Gelinas, Deborah
    Mehrabyan, Anahit
    DiCapua, Daniel
    Howard, James
    MUSCLE & NERVE, 2022, 66 : S140 - S141
  • [26] Serum Markers Associated with Clinical Response Measures in Rheumatoid Arthritis Patients Treated with Golimumab, a New Human Anti-TNFα Monoclonal Antibody
    Visvanathan, Sudha
    Rahman, Mahboob
    Elashoff, Michael
    Wagner, Carrie
    CLINICAL IMMUNOLOGY, 2009, 131 : S77 - S77
  • [27] Increased expression of P2X7 receptor in peripheral blood mononuclear cells correlates with clinical severity and serum levels of Th17-related cytokines in patients with myasthenia gravis
    Zhang, Yong
    Zhang, Yanyan
    Li, Hao
    Jia, Xiao
    Zhang, Xiuying
    Xia, Yan
    Wang, YuZhong
    Fu, Linlin
    Xiao, Chenghua
    Geng, Deqin
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2017, 157 : 88 - 94
  • [28] Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab
    Nakajima, Shoko
    Naruto, Takuya
    Miyamae, Takako
    Imagawa, Tomoyuki
    Mori, Masaaki
    Nishimaki, Shigeru
    Yokota, Shumpei
    MODERN RHEUMATOLOGY, 2009, 19 (01) : 42 - 46
  • [29] Correlation of tumor necrosis factor alpha (TNF-α) serum level with clinical response in rheumatoid arthritis (RA) patients treated by infliximab an anti-TNF-α monoclonal antibody.
    Edrees, AF
    Abdou, NI
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S139 - S139
  • [30] Serum C-X-C Chemokine Ligand 1 Levels in Patients with Systemic Sclerosis: Relationship of Clinical and Laboratory Observations to Anti-CD20 Monoclonal Antibody Administration
    Kawanabe, Ruriko
    Yoshizaki, Ayumi
    Matsuda, Kazuki M.
    Kotani, Hirohito
    Hisamoto, Teruyoshi
    Norimatsu, Yuta
    Kuzumi, Ai
    Fukasawa, Takemichi
    Ebata, Satoshi
    Yoshizaki-Ogawa, Asako
    Sato, Shinichi
    LIFE-BASEL, 2022, 12 (05):
1234